Evidence map›Paper›PMID 32195245›Full record

ArticleFrontiers in cell and developmental biology2020

Fc-Linked IgG

Olga O Zaytseva, Michaela Seeling, Jasminka Krištić, Gordan Lauc, Marija Pezer, Falk Nimmerjahn

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Embryonic reprogramming of the tumor vasculature reveals targets for cancer therapy.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Olga O ZaytsevaGlycoscience Research Laboratory, Genos Ltd., Zagreb, Croatia.
Michaela SeelingDivision of Genetics, Department of Biology, University of Erlangen-Nürnberg, Erlangen, Germany.
Jasminka KrištićGlycoscience Research Laboratory, Genos Ltd., Zagreb, Croatia.
Gordan LaucGlycoscience Research Laboratory, Genos Ltd., Zagreb, Croatia.
Marija PezerGlycoscience Research Laboratory, Genos Ltd., Zagreb, Croatia.
Falk NimmerjahnDivision of Genetics, Department of Biology, University of Erlangen-Nürnberg, Erlangen, Germany.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEScience Research Laboratory · USGenos (Croatia) · HRUniversity of Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunoglobulin G (IgG) is the most abundant immunoglobulin isotype in the blood and is involved in the pathogenesis and progression of various diseases. Glycosylation of the IgG fragment crystallizable (Fc) region is shown to vary in different physiological and pathological states. Fc

Indexed as

Fcγ receptorIgG N-glycan profileimmunoglobulin Gliquid chromatography–electrospray ionization–mass spectrometryN-glycosylation

Identifiers

PMID32195245
PMCPMC7063467
OpenAlexW3009724700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.